EP1181022A4 - Medicinal compositions and their method of preparation - Google Patents
Medicinal compositions and their method of preparationInfo
- Publication number
- EP1181022A4 EP1181022A4 EP00913972A EP00913972A EP1181022A4 EP 1181022 A4 EP1181022 A4 EP 1181022A4 EP 00913972 A EP00913972 A EP 00913972A EP 00913972 A EP00913972 A EP 00913972A EP 1181022 A4 EP1181022 A4 EP 1181022A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparation
- medicinal compositions
- medicinal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP968699 | 1999-04-09 | ||
AUPP9686A AUPP968699A0 (en) | 1999-04-09 | 1999-04-09 | Therapeutic compositions and method for their preparation |
PCT/AU2000/000300 WO2000061153A1 (en) | 1999-04-09 | 2000-04-10 | Medicinal compositions and their method of preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1181022A1 EP1181022A1 (en) | 2002-02-27 |
EP1181022A4 true EP1181022A4 (en) | 2004-02-11 |
Family
ID=3813885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00913972A Withdrawn EP1181022A4 (en) | 1999-04-09 | 2000-04-10 | Medicinal compositions and their method of preparation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1181022A4 (en) |
AU (1) | AUPP968699A0 (en) |
CA (1) | CA2369272A1 (en) |
WO (1) | WO2000061153A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
DE60207878T2 (en) * | 2001-09-28 | 2006-08-17 | Glycomed Sciences Ltd., Turramurra | SOLVENT EXTRACTION PROCESS |
AU2002350513A1 (en) * | 2001-10-09 | 2003-04-22 | Glycomed Sciences Limited | Use of solasonine for the treatment of skin tumors |
WO2003030915A1 (en) * | 2001-10-09 | 2003-04-17 | Glycomed Sciences Limited | Use of solamargine for treating skin tumors |
US6984725B2 (en) | 2002-06-28 | 2006-01-10 | Solbec Pharmaceuticals Ltd. | Method for the separation of triglycoalkaloids |
AUPS326302A0 (en) * | 2002-06-28 | 2002-07-18 | Solbec Pharmaceuticals Limited | Method for the separation of solamargine and solasonine |
AU2003900194A0 (en) * | 2003-01-15 | 2003-01-30 | Solbec Pharmaceuticals Limited | Methods of modulating il-6 |
TWI300352B (en) | 2003-06-05 | 2008-09-01 | G & E Herbal Biotechnology Co Ltd | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
PT1508334E (en) * | 2003-08-22 | 2010-05-04 | G & E Herbal Biotechnology Co | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
GB0513881D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
GB0329667D0 (en) | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
WO2006092017A1 (en) * | 2005-03-02 | 2006-09-08 | Solbec Pharmaceuticals Limited | Glycoalkaloid and tlr agonist combinations and various uses thereof |
GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
WO2007038421A2 (en) * | 2005-09-27 | 2007-04-05 | University Of Kentucky Research Foundation | Berry preparations and extracts |
TWI414304B (en) * | 2011-05-04 | 2013-11-11 | G & E Herbal Biotechnology Co Ltd | Treatment of wart with a water soluble extract from plant of solanum genus |
TWI476012B (en) * | 2011-05-12 | 2015-03-11 | G & E Herbal Biotechnology Co Ltd | Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water soluble extract from plant of solanum genus |
JP6001060B2 (en) * | 2011-06-06 | 2016-10-05 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | Methods for inhibiting muscle atrophy |
CN105192820A (en) * | 2015-08-20 | 2015-12-30 | 泰山医学院 | Blood-fat-reducing cordyceps militaris polysaccharide beverage and preparing method thereof |
EP3423066A4 (en) * | 2016-03-03 | 2019-10-30 | Bill Elliot Cham | Glycoalkaloid combinations and various uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU540812B2 (en) * | 1979-05-02 | 1984-12-06 | Aruba Qld Pty. Ltd. | Steroid alkaloids |
DE69131861T2 (en) * | 1990-01-18 | 2000-05-18 | Cura Nominees Pty Ltd | GLYCOAL CALALID |
-
1999
- 1999-04-09 AU AUPP9686A patent/AUPP968699A0/en not_active Abandoned
-
2000
- 2000-04-10 CA CA002369272A patent/CA2369272A1/en not_active Abandoned
- 2000-04-10 WO PCT/AU2000/000300 patent/WO2000061153A1/en active IP Right Grant
- 2000-04-10 EP EP00913972A patent/EP1181022A4/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
CA2369272A1 (en) | 2000-10-19 |
EP1181022A1 (en) | 2002-02-27 |
WO2000061153A1 (en) | 2000-10-19 |
AUPP968699A0 (en) | 1999-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1181022A4 (en) | Medicinal compositions and their method of preparation | |
PL351948A1 (en) | Implantable gel compositions and method of making thereof | |
EP1227821A4 (en) | Therapeutic compositions and methods of use thereof | |
HUP0105021A3 (en) | Compositions having improved delivery of actives and process for their preparation | |
HUP0202338A3 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
HK1048247A1 (en) | Stable carotene-xanthophyll beadlet compositions and methods of use | |
PL354168A1 (en) | Pharmaceutical composition of nateglinide and another antidiabetcagent | |
PL341566A1 (en) | Oral composition of yttraconasole preparation and method of obtaining same | |
HUP0004802A3 (en) | Nicotine compositions and methods of formulation thereof | |
PL355844A1 (en) | Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation | |
HUP0301192A3 (en) | Pharmaceutical composition of topiramate and process for its preparation | |
HUP0200548A2 (en) | Pharmaceutical compositions and their use | |
HUP0302499A3 (en) | Pharmaceutical compositions of estrogen-cyclodextrin complexes and process for their preparation | |
HUP0202622A3 (en) | Soy milk compositions and methods of preparation | |
HUP0104762A3 (en) | Pharmaceutical moxifloxacin compositions and process for their preparation | |
ZA986437B (en) | Derivatives of acyl-piperazinyl-pyrimidines their preparation and application as medicaments | |
HUP0202862A3 (en) | Pharmaceutical composition containing novel combination of loteprednol and antihistamines | |
HUP0105160A3 (en) | Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them | |
HUP0202654A3 (en) | Pharmaceutical compositions of fibrinolytic agent and process for preparation thereof | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
GB2343117B (en) | Benzimidazole pharmaceutical composition and process of preparation | |
AP2001002371A0 (en) | Streptogramin derivatives preparation and compositions containing them | |
HUP0303731A3 (en) | Sulfonylguanidines and their use for preparation of pharmaceutical compositions | |
HUP0201667A2 (en) | Oral form of administration | |
GB0100757D0 (en) | Prophylactic and therapeutic immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011203 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040102 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 35/00 A Ipc: 7A 61K 31/706 B Ipc: 7A 61P 17/00 B |
|
17Q | First examination report despatched |
Effective date: 20041216 |
|
RTI1 | Title (correction) |
Free format text: GLYCOALKALOID MEDICINAL COMPOSITIONS AND THEIR METHOD OF PREPARATION |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100316 |